BioPharma Resources

Drug Trial Radar · NCT07150845

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults With Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

Aug 26, 2025

Primary completion

Jul 23, 2026

Study completion Aug 3, 2026

Sponsor

Lead sponsor
Evommune, Inc.Industry
Sponsor type
Industry
First posted
Sep 2, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • EVO756Drug

    Dose 1

  • EVO756Drug

    Dose 2

  • EVO756Drug

    Dose 3

  • Placebo controlDrug

    Placebo control

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change in Eczema Area and Severity Index (EASI) from BaselineTime frame: Week 12

Locations

29 sites in 2 countries. Site status is shown where the registry gives one.

  • Saguaro Dermatology

    Phoenix, Arizona

  • Center for Dermatology Clinical Research

    Fremont, California

  • Metropolis Dermatology - Downtown Los Angeles

    Los Angeles, California

  • Skin and Beauty Center

    Pasadena, California

  • Skin Care Research, LLC

    Boca Raton, Florida

  • Driven Research, LLC

    Coral Gables, Florida

  • Skin Care Research - Hollywood Dermatology

    Hollywood, Florida

  • TrueBlue Clinical Research

    Tampa, Florida

  • DS Research

    Clarksville, Indiana

  • Equity Medical

    Bowling Green, Kentucky

  • Aesthetic and Dermatology Center

    Rockville, Maryland

  • Great Lakes Research Group, Inc.

    Bay City, Michigan

  • Revival Research Institute, LLC

    Troy, Michigan

  • Michigan Dermatology Institute

    Waterford, Michigan

  • MediSearch Clinical Trials

    Saint Joseph, Missouri

  • Empire Dermatology

    East Syracuse, New York

  • Equity Medical

    New York, New York

  • Skin Search of Rochester, Inc.

    Rochester, New York

  • Wilmington Dermatology Center

    Wilmington, North Carolina

  • DOCS Dermatology Clinical Research

    Canal Winchester, Ohio

  • International Clinical Research - Murfreesboro

    Murfreesboro, Tennessee

  • Stryde Research

    Lewisville, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • Jordan Valley Dermatology Center

    South Jordan, Utah

  • Pacific Clinical Research Network (PCRN) - Christchurch

    Christchurch Central City, Christchurch, New Zealand

  • Optimal Clinical Trials

    Auckland, NZL, New Zealand

  • Optimal Clinical Trials

    Auckland, NZL, New Zealand

  • Clinical Trials NZ Limited

    Hamilton, NZL, New Zealand

  • Momentum Clinical Research Lower Hutt

    Lower Hutt, NZL, New Zealand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.